No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Sandoz’s Q3/9M Results: Strong Biosimilars Growth of 37%/32%
On 30 October 2024, Sandoz announced its Q3 and 9-month 2024 financial results, reporting third quarter net sales of USD 2.6 billion, up 12% in constant currencies, year-on-year. Net sales for the first 9 months of the year were USD 7.6 billion, an increase of 9% in...